Innovative Eyewear (NASDAQ:LUCY – Get Free Report) and Tenon Medical (NASDAQ:TNON – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, valuation, profitability and institutional ownership.
Institutional & Insider Ownership
1.0% of Innovative Eyewear shares are held by institutional investors. Comparatively, 22.7% of Tenon Medical shares are held by institutional investors. 1.7% of Innovative Eyewear shares are held by insiders. Comparatively, 17.7% of Tenon Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for Innovative Eyewear and Tenon Medical, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Innovative Eyewear | 1 | 1 | 0 | 0 | 1.50 |
| Tenon Medical | 1 | 0 | 1 | 0 | 2.00 |
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Innovative Eyewear | -225.26% | -88.90% | -80.34% |
| Tenon Medical | -257.85% | -907.60% | -124.84% |
Risk and Volatility
Innovative Eyewear has a beta of 2.74, meaning that its share price is 174% more volatile than the S&P 500. Comparatively, Tenon Medical has a beta of 1.35, meaning that its share price is 35% more volatile than the S&P 500.
Valuation and Earnings
This table compares Innovative Eyewear and Tenon Medical”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Innovative Eyewear | $2.66 million | 2.91 | -$7.59 million | ($1.29) | -0.69 |
| Tenon Medical | $3.94 million | 0.63 | -$12.56 million | ($44.87) | -0.08 |
Innovative Eyewear has higher earnings, but lower revenue than Tenon Medical. Innovative Eyewear is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.
Summary
Innovative Eyewear beats Tenon Medical on 7 of the 13 factors compared between the two stocks.
About Innovative Eyewear
Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.
About Tenon Medical
Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
Receive News & Ratings for Innovative Eyewear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovative Eyewear and related companies with MarketBeat.com's FREE daily email newsletter.
